Serpin A1

Serpin A1

Serpin A1 Overview

Molecule Name
Alpha-1-antiproteinase
Synonyms
SerpinA1,PI,A1A,AAT,PI1,A1AT,MGC9222,PRO2275,MGC23330,alpha1AT,SPAAT
Drug Development Progress
Drugs in Clinical Trials14
Approved Drugs2
Highest Development StageApproved
Target Synonym
Alpha-1-antiproteinase,PRO2209,Serpin Family A Member 1,alpha 1-Antitrypsin,Protease Inhibitor 1 (Anti-Elastase), Alpha-1-Antitrypsin,Alpha-1 Protease Inhibitor,Serpin A1,AAT,PI,Serpin Peptidase Inhibitor Clade A (Alpha-1antiproteinase, Antitrypsin) Member 1,Serine (Or Cysteine) Proteinase Inhibitor, Clade A, Member 1,Alpha-1-Antitrypsin Short Transcript Variant 1C4,Serpin Peptidase Inhibitor Clade A Member 1,Alpha-1-Antitrypsin Null,Alpha-1 Antitrypsin,Alpha-1-Antitrypsin,Alpha1AT,PRO2275,NNIF,A1A,PI1,Epididymis Secretory Sperm Binding Protein,Serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 1,Serine (Or Cysteine) Proteinase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 1,Alpha-1-Antitrypsin Short Transcript Variant 1C5,A1AT,PRO0684,SPAAT,SERPINA1
Background
Serpin A1 is also known as Alpha-1-antitrypsin (A1AT), serum trypsin inhibitor, alpha-1 proteinase inhibitor (A1PI), AAT, which belongs to the serpin family. Most serpins inactivate enzymes by binding to them covalently, requiring very high levels to perform their function. Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Serpin A1 / A1AT is inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form of SerpinA1 inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin. Serpin A1 / A1AT protects tissues from enzymes of inflammatory cells, especially neutrophil elastase. Defects in SERPINA1 are the cause of alpha-1-antitrypsin deficiency (A1ATD).

Serpin A1 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
FazirsiranTAK-999; ADS-001; ARO-AATPhase 3 ClinicalArrowhead Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd
alpha 1-Antitrypsin Deficiency; Hepatic Insufficiency
Details
YOLT-202YOLT-202Phase 3 ClinicalShanghai Yaotang Biotechnology Co Ltd
alpha 1-Antitrypsin Deficiency; Genetic Diseases, Inborn
Details
Efdoralprin alfaINBRX-101; AT-292; rhAAT-Fc; AAT-IgG-Fc; AAT-Fc; SAR447537; SAR-447537Phase 2 ClinicalArecor Ltd, Inhibrx
alpha 1-Antitrypsin Deficiency; Emphysema
Details
TSRA-196TSRA-196Phase 2 ClinicalTessera Therapeutics Inc
alpha 1-Antitrypsin Deficiency
Details
VX-864VX-864Phase 2 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
Details
KRRO-110KRRO-110Phase 2 ClinicalKorro Bio Inc
alpha 1-Antitrypsin Deficiency
Details
WVE-006WVE-006; GSK-5462688Phase 2 ClinicalWave Life Sciences Ltd
alpha 1-Antitrypsin Deficiency
Details
BEAM-302α1-AD; α-1-AD; BEAM-302Phase 2 ClinicalBeam Therapeutics Inc
alpha 1-Antitrypsin Deficiency
Details
adeno-associated virus gene therapy (University of Massachusetts/University of Florida/NHLBI)Phase 1 ClinicalUniversity of Massachusetts
alpha 1-Antitrypsin Deficiency
Details
KB-408KB-408Phase 1 ClinicalKrystal Biotech Inc
alpha 1-Antitrypsin Deficiency
Details
VX-668VX-668; VX668Phase 1 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
Details
VX-634VX-634Phase 1 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
Details
BMN-349BMN-349Phase 1 ClinicalBiomarin Pharmaceutical Inc
alpha 1-Antitrypsin Deficiency
Details
Alpha-1 antitrypsin (Kalytera Therapeutics)ClinicalClalit Health Services
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Alpha1-proteinase inhibitor (Human, Grifols)TAL-6004ApprovedBayer AG, Grifols SaProlastin, Prolastin-cUnited Statesalpha 1-Antitrypsin Deficiencynull1987-12-02
alpha 1-Antitrypsin Deficiency; Coronavirus Disease 2019 (COVID-19); Cystic Fibrosis; Pancreatitis, Chronic; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema
Details
Alfalastin (LFB SA)ApprovedLfb Biotechnologies SasAlfalastinFrancealpha 1-Antitrypsin DeficiencyLfb Biotechnologies Sas2005-08-01
alpha 1-Antitrypsin Deficiency
Details